摘要
目的分析包头肿瘤医院抗肿瘤药物应用情况,作出客观评估,为该类药物的临床应用提供参考。方法采用金额排序法和用药频度分析法对该院2008～2010年抗肿瘤药物的使用情况进行统计。结果按金额排序,中药、抗代谢药及抗肿瘤植物药是抗肿瘤治疗的主要用药,三类药物占总销售金额的近70%;用药频度排名前三位药品分别是他莫西芬、托瑞米芬、来曲唑,三种药物3年分别占总用药强度的47.8%、44.4%、50.1%。结论该院抗肿瘤药物用药金额与用药频度呈逐年上升趋势;肿瘤治疗应考虑疗效与经济成本等多种因素,优化治疗方案、实现个体化给药,从而提高肿瘤联合治疗效果,节约抗肿瘤药物资源。
Objective To analyze the application of antitumor drugs in Baotou Cancer Hospital, make an objective evaluation, and provide a reference for clinical use. Method By the order of total cost and DDDs, the use of antitumor drugs from 2008 to 2010 was made a statistical analysis. Results According to amount of sales value, the top 3 antitumor drugs were traditional Chinese drugs, antimetabolite and antitumor plant, and total number of users and sales amount was nearly 70% in drugs. According to DDDs, the top 3 drugs were tamoxifen, toremifene and lelrozole, and they were r^pectively 47.8%, 44.4% and 50.1% in total DDDs in there years. Conclusion In Baotou Cancer hospital, the amount of annual consumption and the DDDs of anticancer drugs were adscendent tendency in the lately years. Such multiple factors should be taken into account as cancer therapy, treatment, economic costs, and treatment optimization, and achieve individual administration, thereby enhancing anti-tumor effect of combination therapy that saves the resources of anticancer drugs.
出处
《肿瘤药学》
CAS
2011年第4期387-390,共4页
Anti-Tumor Pharmacy
关键词
抗肿瘤药物
用药分析
用药金额
用药频度
Antitumor drugs
Analysis of drug use
Money comsum
Medication fruquence
